| 000 | 01797 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517195855.0 | ||
| 264 | 0 | _c20181119 | |
| 008 | 201811s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.1080/0284186X.2018.1433322 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChristensen, Troels Dreier | |
| 245 | 0 | 0 |
_aAssociations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cAug 2018 |
||
| 300 |
_a1057-1062 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aClass I Phosphatidylinositol 3-Kinases _xgenetics |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aPeritoneal Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSkin Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aras Proteins _xgenetics |
| 700 | 1 | _aPalshof, Jesper Andreas | |
| 700 | 1 | _aLarsen, Finn Ole | |
| 700 | 1 | _aPoulsen, Tim Svenstrup | |
| 700 | 1 | _aHøgdall, Estrid | |
| 700 | 1 | _aPfeiffer, Per | |
| 700 | 1 | _aJensen, Benny Vittrup | |
| 700 | 1 | _aYilmaz, Mette Karen | |
| 700 | 1 | _aNielsen, Dorte | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 57 _gno. 8 _gp. 1057-1062 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/0284186X.2018.1433322 _zAvailable from publisher's website |
| 999 |
_c28024554 _d28024554 |
||